Journal List > Korean J Gynecol Oncol Colposc > v.5(2) > 1123822

Korean J Gynecol Oncol Colposc. 1994 Jun;5(2):59-65. Korean.
Published online Mar 13, 2019.  https://doi.org/10.3802/kjgoc.1994.5.2.59
Copyright © Korean Society of Gynecologic Oncology and Colposcopy
Efficacy of Serum CA 125 and Ca 15-3 Levels in Appraently Healthy Women for Ovarian Cancer Screening
JS Han, YM Kim, YT Kim, JH Nam and JE Mok
Abstract

OBJECTIVE

The objective was to determine the efficacy of CA 15-3 as a complimentary marker to CA 125 for ovarian cancer screening.

STUDY DESIGN

Serum CA 125 and CA 15-3 levels were measured by immunoradiometric asaay in 550 apparently healthy women and 46 ovarian cancer.

RESULTS

The cut-off level of serurn CA 125 in the apparently healthy women were 65.0 U/ml in the under 50 age group and 34.8 U/ml in the over 50 age group, And the cut-off level of serum CA 15-3 were 37.0 U/ml and 34.7 U/ml, respectively. The sensitivity of serum CA 125 were 95.7% at the cut-off level of 35 U/ml and 93.5% at the cut-off level of 65 U/ml. And that of serum CA15-3 were 52.2% at the cut off level of 30 U/ml and 45.7% at the cut off level of 40 U/ml. The specificity of serum CA 125 were 95.6%(35 U/ml) and 99.3 %(65 U/ml). And that of serum CA 15-3 were 98.3(30 U/ml) and 99.6%(40 U/ml).

CONCLUSION

The serum CA 15-3 assay combination with CA 125 would not contribute to increase the efficacy of screening strategy for ovarian cancer. The serum CA 125 is very useful tumor marker in ovrian cancer screening, especially in the over 50 age group and at 35 U/ml cut-off level.

TOOLS
Similar articles

Serum CA 125 Levels in Patients with Impaired Renal Function

Significance of Serum CA 125 and CA 15-3 Levels in Patients with Ovarian Tumor

Clinical efficacy of serum human epididymis protein 4 as a diagnostic biomarker of ovarian cancer: A pilot study

Diagnostic Efficiency of Peritoneal Fluid and Serum Lactate Dehydrogenase(LDH) in Ovarian Cancer Patients

Correlation between preoperative serum levels of five biomarkers and relationships between these biomarkers and cancer stage in epithelial overian cancer